GLP-1R/GIPR/GCGR agonists (Nonirui Biotechnology)

N/A

Report date: 2026/04/10 20:01:49
NME

Base Information

Drug NameGLP-1R/GIPR/GCGR agonists (Nonirui Biotechnology)
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGlucose-Dependent Insulinotropic Polypeptide Receptor agonistsGlucagon receptor agonists
TargetsGlucagon-like peptide 1 receptorGlucose-Dependent Insulinotropic Polypeptide ReceptorGlucagon receptor
Therapy Area/IndicationsObesityMetabolic SyndromeDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Nonirui Biotechnology Co ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Nonirui Biotechnology Co ltd
Inactive CompaniesN/A
Active IndicationsObesityMetabolic SyndromeDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A